Certis Oncology Solutions

About Certis Oncology Solutions

Certis Oncology Intelligence combines powerful predictive AI with advanced preclinical models to provide clear evidence of therapeutic efficacy in cancer treatment, focusing on innovation, collaboration, and precision in drug development.

Products & Services

CertisAI™:A predictive oncology intelligence platform using AI to enhance drug development.

Cancer Models:Preclinical cancer models for drug testing and studies.

Custom Model Development:Tailored model development for specific research needs.

In Vitro/Ex Vivo Pharmacology:Pharmacological testing services outside the living organism.

Imaging/Endpoint Analysis:Advanced imaging and analysis for research endpoints.

Immuno-Oncology:Solutions focused on cancer immunotherapy research.

Order YourPDX(r):Patient-derived xenograft models for oncologists.

Clinical Research:Support for clinical research in oncology.

Patient Education:Educational resources for patients and oncologists.

Specialties

Predictive Oncology Intelligence AI in Drug Development Preclinical Cancer Models Immuno-Oncology Patient-Derived Xenografts (PDX)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2024-01-17 FD: 2024-01-17	2 investors

Series C Latest

2024-01-17

$10.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

James H. Berglund

Director

S

Stephen Bonner

Director

F

Frederick (Fritz) C. Eilber

Professor of Surgery, Division of Surgical Oncology

P

Peter Ellman

Chief Executive Officer

J

J. Mark Grosvenor

Director

A

Arun S. Singh

Medical Oncologist

View 17 more team members with Pro

Unlock Full Team Directory

Recent News